Klarquist Sparkman, LLP
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
The present disclosure relates to oligodeoxynucleotides that suppress an immune response. Methods are disclosed for inhibiting or treating inflammatory lung disease by administering a therapeutically effective amount of a suppressive oligodeoxynucleotide.
The United States of America as represented by the Secretary of the Department of Health and Human Services
A A C A C A A
A61P A61P C12N A61P C12N A61P A61P
inventional inventional inventional inventional additional inventional inventional
Hiroshi Dennis M.
Yamada Klinman